Sechenov School
Home › Pathology › Thrombocytopathia

Thrombocytopathia and Platelet Disorders

Thrombocytopathia

For medical students2 min readUpdated 2026-10-10

Thrombocytopathia refers to a group of inherited disorders and acquired syndromes characterized by functionally defective platelets. Platelet counts in peripheral blood are typically normal, but the cells fail to adequately perform their role in primary hemostasis.

Platelet CountUsually remains within the normal range; the condition is not necessarily accompanied by thrombocytopenia.
MorphologyAnisocytosis and abnormal forms, such as 'gray platelets', are characteristic.
OriginCan present either as primary inherited disorders or as acquired secondary syndromes.
Factor DeficienciesOften associated with a deficiency of von Willebrand factor or thrombin-sensitive proteins.

Pathogenesis and Etiology of Functional Impairment

Impairments in thrombocytopathia occur at a deep cellular level. The key pathogenic mechanisms include:

The etiology of acquired forms of thrombocytopathia includes:

Thrombocytosis: Classification and Causes

In contrast to functional impairment, thrombocytosis represents a pathological increase in the absolute number of platelets in peripheral blood. Generally, all forms of thrombocytosis are divided into two major categories:

  1. Reactive thrombocytosis. These are always transient in nature. Their causes include:
  2. Splenectomy (surgical removal of the spleen).
  3. Acute blood loss or acute hemolysis.
  4. Early and late postoperative periods.
  5. Malignant neoplasms.
  6. Severe inflammatory and infectious processes, such as tuberculosis or osteomyelitis.
  7. Autoimmune and systemic pathologies, including rheumatoid arthritis and ulcerative colitis.
  1. Clonal (neoplastic) thrombocytosis. Results from malignant cell transformation. It is found in myeloid leukemias and various myeloproliferative neoplasms.

The Paradox of Thrombocytosis: From Thrombi to Hemorrhage

The clinical presentation of thrombocytosis has a paradoxical character. A massive pool of circulating platelets initially triggers severe microcirculatory pathology, causing widespread intravascular coagulation.

However, this process leads to the rapid consumption of plasma clotting factors, subsequently resulting in a hemorrhagic syndrome (bleeding manifestations).

An extreme manifestation of this pathological cascade is essential thrombocythemia. This is a specific hyperthrombocytosis state in which the platelet count exceeds 1 million/µL, inevitably accompanied by a severe hemorrhagic diathesis.

Thrombophilia (Thrombotic Disease)

Thrombophilia is a pathological condition characterized by a heightened propensity for intravascular blood coagulation and thrombus formation.

The pathogenesis is driven by various environmental and internal factors. These triggers induce excessive thrombin generation, ultimately leading to thrombosis. Further classification of this condition is based on its origin.

Mnemonic

To avoid confusing terms: thrombocytopathia means cells are 'sick' (non-functional, but normal in number); thrombocytosis means too many cells; thrombocytopenia means too few cells.

Frequently asked questions

Which inherited disorders are classified as thrombocytopathias?

Inherited thrombocytopathias comprise a broad group of genetically determined disorders. Major forms include:

  • Chédiak–Higashi syndrome — dysfunction caused by abnormal platelet structure.
  • von Willebrand disease — combined defect with deficiency of factor VIII/vWF.
  • Bernard–Soulier syndrome — glycoprotein deficiency accompanied by giant megakaryocytes and platelets.
  • Wiskott–Aldrich syndrome — presence of microplatelets.
  • Fanconi anemia — hematopoietic stem cell defect.
  • Glanzmann thrombasthenia — absence of the glycoprotein IIb/IIIa complex on the plasma membrane.
  • Congenital afibrinogenemia — fibrinogen deficiency or integrin defect.

Other entities include gray platelet syndrome, Quebec platelet disorder, Paris-Trousseau syndrome, Hermansky-Pudlak syndrome, and TAR syndrome.

How are thrombocytopathias classified based on the impaired platelet function?

Depending on the affected stage of primary hemostasis, inherited thrombocytopathias are classified into four main groups:

  • Adhesion disorders — impaired attachment to the subendothelium due to receptor defects or binding protein abnormalities (Bernard–Soulier syndrome, von Willebrand disease).
  • Aggregation disorders — impaired platelet-to-platelet clumping (Glanzmann thrombasthenia, congenital afibrinogenemia).
  • Degranulation disorders — storage pool diseases associated with the absence of specific granules or defective release of their contents (alpha-granule deficiency, dense delta-granule deficiency, or combined deficiencies).
  • Signal transduction and platelet formation defects — intracellular signaling aberrations at the receptor level and structural anomalies.
What types of bleeding and clinical manifestations are characteristic of thrombocytopathias?

Thrombocytopathias are characterized by a petechial-purpuric (microcirculatory) bleeding pattern. Clinical manifestations include:

  • Cutaneous hemorrhages — painless asymmetric bruising, small pinpoint hemorrhages (petechiae), and ecchymoses.
  • Mucosal bleeding — recurrent spontaneous or disproportionate mucocutaneous bleeding, including gastrointestinal bleeding.
  • Menorrhagia — heavy menstrual bleeding in females.
  • Postoperative hemorrhages — bleeding that occurs immediately after trauma or surgical procedures.

Platelet counts in thrombocytopathias are often normal, though qualitative platelet defects can occasionally coincide with thrombocytopenia.

Is the platelet count always decreased in thrombocytopathia?

No, the platelet count is usually normal. The core issue is their functional impairment rather than a quantitative deficit.

Why does thrombocytosis (an excess of platelets) cause bleeding?

A massive number of platelets causes microthrombosis, rapidly consuming clotting factors. Their depletion leads to a paradoxical hemorrhagic syndrome.

What morphological changes in platelets are visible under a microscope in thrombocytopathia?

The pathology is characterized by anisocytosis (presence of cells of varying sizes) and the appearance of specific abnormal forms, such as 'gray platelets'.

Go deeper

More topics in Pathology

BronchiectasisCoagulopathiesThromboangiitis ObliteransThrombocytopeniaGiant Cell ArteritisDiseases of the Anal CanalKawasaki DiseaseHemorrhoids: Pathology, Anatomy and ComplicationsHemorrhagic VasculitisIdiopathic Interstitial PneumoniasPolyarteritis Nodosa: Pathogenesis and MorphologyColorectal CancerPathology →